Molecular Imaging 2017

PIRADS v2

Scoring:  1: Very low, clinically significant PCa highly unlikely  2: Low, clinically significant PCa is unlikely  3: Intermediate, equivocal presence of clinically significant PCa  4: High, clinically significant PCa likely  5: Very high, clinically significant Pca highly likely

http://www.acr.org/ ∼ /media/ACR/Documents/PDF/QualitySafety/Resources/PIRADS

Barentsz J et al. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol 2016; 69: 41-9.